Showing results (481-490 of 542) with videos related to
Sort By:
Pageof 55
The Journal of Pathology|December 6, 2013
The genomic landscape of oesophagogastric junctional adenocarcinomaIrene Y Chong, David Cunningham, Louise J Barber, et al.European Journal of Cancer (Oxford, England : 1990)|April 10, 2024
Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trialsAlessandra Raimondi, Young Woo Kim, Won Ki Kang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C TrialGayathri Anandappa, Andrea Lampis, David Cunningham, et al.Journal of Psychopharmacology (Oxford, England)|December 13, 2019
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyThomas Re Barnes, Richard Drake, Carol Paton, et al.Oncotarget|October 15, 2017
Molecular profiling of colorectal pulmonary metastases and primary tumours: implications for targeted treatmentSing Y Moorcraft, Thomas Jones, Brian A Walker, et al.American Journal of Hematology|March 4, 2021
Relapsed/Refractory International Prognostic Index (R/R-IPI): An international prognostic calculator for relapsed/refractory diffuse large B-cell lymphomaMatthew J Maurer, Lasse H Jakobsen, Raphael Mwangi, et al.Journal for Immunotherapy of Cancer|April 16, 2019
CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoidsReyes Gonzalez-Exposito, Maria Semiannikova, Beatrice Griffiths, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2022
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP StudyJohn Bridgewater, Peter Fletcher, Daniel H Palmer, et al.The Lancet. Haematology|April 29, 2018
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trialMary Gleeson, Clare Peckitt, Ye Mong To, et al.Cancer Discovery|May 15, 2016
High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical TrialAlex Pearson, Elizabeth Smyth, Irina S Babina, et al.Pageof 55